AgomAb Therapeutics NV American Depositary Shares Net Asset Quality Index
AgomAb Therapeutics NV American Depositary Shares net asset quality index. AgomAb Therapeutics NV American Depositary Shares (AGMB) has a Net Asset Quality Index of 88.7% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $165.63 Million minus total liabilities of $18.70 Million yields net assets of $146.93 Million. A higher index indicates a stronger, lower-leverage balance sheet. Explore AGMB cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of AgomAb Therapeutics NV American Depositary Shares (2021–2025)
Net asset quality index of AgomAb Therapeutics NV American Depositary Shares from 2021 to 2025. This chart shows how AgomAb Therapeutics NV American Depositary Shares's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the index stands at 88.7%, representing net assets of $146.93 Million against total assets of $165.63 Million USD. See AGMB book value for net asset value and shareholders' equity analysis.
AgomAb Therapeutics NV American Depositary Shares Net Asset Quality Index by Year (2021–2025)
AgomAb Therapeutics NV American Depositary Shares net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for AgomAb Therapeutics NV American Depositary Shares from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see AGMB market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 85.2% | $130.90 Million | $153.71 Million | $22.80 Million | ▼ -6.0 pp |
| 2024 | 91.1% | $188.08 Million | $206.36 Million | $18.28 Million | ▲ +2.7 pp |
| 2023 | 88.4% | $151.44 Million | $171.26 Million | $19.82 Million | ▲ +22.8 pp |
| 2022 | 65.6% | $66.25 Million | $101.00 Million | $34.75 Million | ▲ +15.2 pp |
| 2021 | 50.4% | $42.36 Million | $84.00 Million | $41.63 Million | — |